Olga V Kovaleva1, Vasiliy V Sinyov1, Madina A Rashidova1

  • 1Institute of Experimenal Oncology and Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.

Frontiers in immunology
|February 18, 2026
PubMed
概括

与瘤相关的中性粒细胞 (TANs) 和中性粒细胞外细胞陷 (NETs) 驱动激进细胞癌 (RCC) 的进展和耐治疗性. 针对这些中性粒细胞成分提供了有前途的治疗策略,以改善患者的治疗结果.